Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Pegfilgrastim (Neulasta®) Application Via Manual Injection Versus Injection Via an On-body Injector Regarding Patient Preference and Health Economics

NCT03619993 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT03619993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03619993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Pegfilgrastim (Neulasta®) Application Via Manual Injection Versus Injection Via an On-body Injector Regarding Patient Preference and Health Economics
Lead sponsor
iOMEDICO AG
Phase
Not applicable
Overall status
Completed
Start date
June 25, 2018
Completion date
September 10, 2019
Enrollment
404 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, non hodgkin lymphoma